The average older adult with Medicare Part B coverage who is administered one of these drugs would save $800 a year in co-payments. The Trump administration is proposing a new rule on Thursday to keep hospitals from charging markups on discounted drugs for Medicare patients and says that could save consumers $1.1 billion next year, according to estimates obtained by The Associated Press.
Trump administration proposes rule to cut Medicare drug prices by $1.1 billion
Why This Matters
This proposed rule by the Trump administration aims to reduce drug costs for Medicare patients by preventing hospitals from charging markups on discounted medications, potentially saving consumers $1.1 billion annually. Such measures could significantly ease the financial burden on older adults and improve access to essential medications. It also signals a shift towards more transparent and fair pricing practices in the healthcare industry.
Key Takeaways
- Hospitals will be restricted from charging markups on discounted drugs for Medicare patients.
- Consumers could save approximately $800 annually in co-payments per drug.
- The policy aims to save Medicare $1.1 billion next year, impacting healthcare affordability.
Get alerts for these topics